Korean J Dermatol.  1997 Feb;35(1):22-32.

Clinical Investigation and Distribution of Pityrosporum in Patients with Seborrheic Dermatitis of the Scalp

Abstract

BACKGROUND
Seborrheic dermatitis is a very common chronic inflammatory disease. Previous studies suggested that, Pityrosporum, lipophilic fungi, may play an important role in the pathogenesis of the disease.
OBJECTIVE
The purpose of this study was to investigate the disease clinically and mycologically for better understanding of the pathogenesis.
METHODS
Two hundred and one new patient.s with seborrheic dermatitis of the scalp and 67 norrnal subjects were obs!,rved clinically by the dermatologist and studied stat,istically by questionnaires. A mycologic study of Pityrosporum was also performed by direct smear.
RESULTS
Among a total of 201 patients wit,h seborrheic dermatitis, 72.6% had pityriasis sicca, 10.5% had pityr iasis steartoides and 16.9% had inflammatory seborrheic dermatitis. On clinical grading by the Kligman.. scale, grade III(slightly scaling) was the most common in the patients and 52.6% of the norma. subjects were below grade II (no scaling). Spores of Pityrosporum were observed in 76.7% of the patients and 91.5% of the normal subjects. The incidence of Pityrosporum was lower particularly in t,he patients with inflammatory seborrheic dermatitis t,han in other pa~tients groups.
CONCLUSION
According to the results of the study, it, is difficult to conclude that Pityrosporum is a main causative ager t of seborrheic dermatitis. In addition, it is thought t.hat further studies of the role of Pityrosporum in seborrheic dermatitis are needed.

Keyword

Seborrheic der mat it is; Scalp; Clinical investigation; Pityrosporum

MeSH Terms

Dermatitis, Seborrheic*
Fungi
Humans
Incidence
Malassezia*
Pityriasis
Scalp*
Spores
Surveys and Questionnaires
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr